Methods and compositions for targeting HEPSIN

Details for Australian Patent Application No. 2007260950 (hide)

Owner GENENTECH, INC.

Inventors Vij, Rajesh; Kirchhofer, Daniel K.

Agent Griffith Hack

Pub. Number AU-B-2007260950

PCT Pub. Number WO2007/149932

Priority 60/805,589 22.06.06 US

Filing date 20 June 2007

Wipo publication date 27 December 2007

Acceptance publication date 15 September 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/149932 Priority application(s): WO2007/149932

22 January 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name GENENTECH, INC., Application No. 2007260950, under INID(54) amend the title to read Methods and compositions for targeting HEPSIN

15 September 2011 Application Accepted

  Published as AU-B-2007260950

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007260951-Prosthetic valve implantation systems

2007260940-Systems and methods for producing a total product with inorganic salt recovery